Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs MEDICAMEN BI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA MEDICAMEN BI BAL PHARMA/
MEDICAMEN BI
 
P/E (TTM) x 40.8 43.4 93.9% View Chart
P/BV x 2.3 2.5 89.6% View Chart
Dividend Yield % 1.1 0.3 420.7%  

Financials

 BAL PHARMA   MEDICAMEN BI
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
MEDICAMEN BI
Mar-23
BAL PHARMA/
MEDICAMEN BI
5-Yr Chart
Click to enlarge
High Rs1341,219 11.0%   
Low Rs63559 11.3%   
Sales per share (Unadj.) Rs193.9111.4 174.1%  
Earnings per share (Unadj.) Rs1.711.6 14.3%  
Cash flow per share (Unadj.) Rs7.516.7 44.9%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Avg Dividend yield %1.00.1 900.2%  
Book value per share (Unadj.) Rs40.7152.8 26.6%  
Shares outstanding (eoy) m15.6912.65 124.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.58.0 6.4%   
Avg P/E ratio x59.276.4 77.5%  
P/CF ratio (eoy) x13.253.3 24.7%  
Price / Book Value ratio x2.45.8 41.7%  
Dividend payout %59.98.6 697.5%   
Avg Mkt Cap Rs m1,54911,246 13.8%   
No. of employees `000NANA-   
Total wages/salary Rs m553201 274.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0421,409 216.0%  
Other income Rs m925 38.2%   
Total revenues Rs m3,0521,433 212.9%   
Gross profit Rs m253243 103.7%  
Depreciation Rs m9164 143.4%   
Interest Rs m12334 363.0%   
Profit before tax Rs m47170 27.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2123 91.9%   
Profit after tax Rs m26147 17.8%  
Gross profit margin %8.317.3 48.0%  
Effective tax rate %44.813.6 329.9%   
Net profit margin %0.910.5 8.2%  
BALANCE SHEET DATA
Current assets Rs m2,2821,634 139.7%   
Current liabilities Rs m2,093826 253.5%   
Net working cap to sales %6.257.4 10.8%  
Current ratio x1.12.0 55.1%  
Inventory Days Days835 21.8%  
Debtors Days Days1,1281,691 66.7%  
Net fixed assets Rs m8291,062 78.0%   
Share capital Rs m157127 124.0%   
"Free" reserves Rs m4811,806 26.6%   
Net worth Rs m6381,933 33.0%   
Long term debt Rs m3059 3,508.4%   
Total assets Rs m3,1102,766 112.4%  
Interest coverage x1.46.0 23.0%   
Debt to equity ratio x0.50 10,631.2%  
Sales to assets ratio x1.00.5 192.1%   
Return on assets %4.86.6 73.3%  
Return on equity %4.17.6 53.9%  
Return on capital %18.110.5 171.9%  
Exports to sales %66.475.6 87.9%   
Imports to sales %22.46.3 354.7%   
Exports (fob) Rs m2,0201,064 189.8%   
Imports (cif) Rs m68389 766.0%   
Fx inflow Rs m2,0201,064 189.8%   
Fx outflow Rs m716136 526.5%   
Net fx Rs m1,305928 140.5%   
CASH FLOW
From Operations Rs m-18-63 29.3%  
From Investments Rs m-222-59 377.2%  
From Financial Activity Rs m244291 83.8%  
Net Cashflow Rs m4170 2.2%  

Share Holding

Indian Promoters % 47.1 43.2 109.0%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 0.9 14.8%  
FIIs % 0.1 0.2 59.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 56.8 85.9%  
Shareholders   15,060 10,252 146.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs MEDICAMEN BI

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs MEDICAMEN BI Share Price Performance

Period BAL PHARMA MEDICAMEN BI S&P BSE HEALTHCARE
1-Day -4.61% -0.10% 1.18%
1-Month -17.94% -23.09% -0.75%
1-Year 40.62% -38.46% 61.82%
3-Year CAGR 18.95% -9.60% 18.16%
5-Year CAGR 5.38% -4.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the MEDICAMEN BI share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of MEDICAMEN BI the stake stands at 43.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of MEDICAMEN BI.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

MEDICAMEN BI paid Rs 1.0, and its dividend payout ratio stood at 8.6%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of MEDICAMEN BI.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.